Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03041207 · ClinicalTrials.gov registry record

Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection

A clinical trial, sponsored by Virginia Commonwealth University.

Completed
Registry status
555
Enrollment target

NCT03041207: Completed study, sponsored by Virginia Commonwealth University.

NCT03041207 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 555 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03041207 has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
555 participants
Enrollment target

Study Summary

This is a prospective study with three specific aims: (1) To convene a consensus conference to develop a guideline for antibiotic use in infants (age \< 3 yrs) with suspected ventilator-associated infection; (2) To evaluate outcomes before and after implementation of the antibiotic guideline; (3) To evaluate changes in the tracheal microbiome over the course of mechanical ventilation

Primary Outcome

28 - number of days in PICU (death = 0 free days)

Interventions

  • BEHAVIORAL Development and implementation of an antibiotic guideline

Trial Details

FieldValue
Enrollment Target 555 participants
Start Date 2017-03-20
Est. Completion 2019-04-30
Virginia Commonwealth University

558 total trials

What the finished NCT03041207 record still lists

NCT03041207 is an observational study that tracks outcomes without assigning an intervention. The registered 555 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Development and implementation of an antibiotic guideline is the first listed.

NCT03041207 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03041207 about?

NCT03041207 is a clinical study titled "Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection". This is a prospective study with three specific aims: (1) To convene a consensus conference to develop a guideline for antibiotic use in infants (age \< 3 yrs) with suspected ventilator-associated infection; (2) To evaluate outcomes before and after implementation of the antibiotic guideline; (3) To...

What is the current status of trial NCT03041207?

This trial is currently completed. The enrollment target is 555 participants. The study started on 2017-03-20. Estimated completion is 2019-04-30.

What interventions are being tested in trial NCT03041207?

The interventions under investigation include: Development and implementation of an antibiotic guideline (BEHAVIORAL).

Who is sponsoring clinical trial NCT03041207?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06799000 · 555 participants · Phase 3

    A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

  • NCT06840392 · 555 participants · Phase 3

    A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  • NCT06074588 · 556 participants · Phase 3

    Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  • NCT06693622 · 556 participants

    Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03041207, the US trial registry maintained by the National Library of Medicine. NCT03041207 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.